German chemical and pharmaceutical giant Bayer announced a multi-billion-euro deal Friday to sell parts of its agrichemical business to its rival Baden Aniline and Soda Factory (BASF), easing the path of its planned takeover of the U.S. seed maker, Monsanto.
The 5.9-billion-euro ($7-billion) deal includes Bayer's glufosinate ammonium herbicide business, "essentially all" of its crop seeds units, related research and development (R&D) activities, and intellectual property, the company said in a statement. Transaction will only go ahead if Bayer's Monsanto merger is approved by the competition authorities and is itself subject to a competition probe.
"We are taking an active approach to address potential regulatory concerns with the goal of facilitating a successful close of the Monsanto transaction," Chief Executive Werner Baumann said. The European Commission (EC) said earlier this month it would put on hold its competition probe of Bayer's $66-billion mega-deal - the largest in German history - to take over the controversial U.S. seeds and pesticides maker Monsanto.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.